1st Symposium on parathyroid fluorescence – On February 28th to March 01st – Geneva (Swiss)

Thyroid and parathyroid surgery are two common surgical procedures that have become very safe thanks to the surgical advances.  However, hypoparathyroidism remains the current concern of thyroid surgery. New fluorescence imagining techniques, have been developed to help the detection of parathyroid glands and confirm their vascularization. This has opened a new exciting area of research for surgeons and scientists.
Moreover, our fluorescence imagining system FLUOEAM® has received the market authorization from FDA to help in real-time localization of parathyroid tissue during procedures such as thyroidectomy or parathyroidectomy.
In this context, we are delighted to see you at this first international symposium and to present to you our fluorescence imaging solutions and their various applications.
We also invite you to our symposium presented by Mrs. Odile ALLARD the CEO of Fluoptics© and Mr. Philippe RIZO the CTO of Fluoptics©, on the latest Fluoptics© innovations. This symposium will take place on February 28th from 6 to 7 pm.
Gilles Boutet

Vice President Sales and Marketing.

"The X factor after which best surgeons of the planet run: FLUOBEAM®. This is the moment to discover it on our booth."

Come on our symposium

t is our great pleasure to invite you to join us in a dedicated and scientific symposium, during the 1st symposium on parathyroid fluorescence.
This symposium will be held on February 28th, from 18.00 to 19.00h in Conference Room.

A great and delicious lunch will be served during this symposium.
Address: Lake Geneva Hotel - Geneva (Swiss)
Main conference:
Challenges in parathyroid identification and preservation
Optical techniques for Parathyroid detection and vascularity assessment
Methodology for Parathyroid Detection and Perfusion
Impact of new techniques of parathyroid detection and preservation on patient outcome